Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts
Pfizer (NYSE: PFE) has announced a conference call with investment analysts scheduled for April 29, 2025, at 10:00 a.m. EDT. The call will provide updates on the company's First Quarter 2025 Performance Report, which will be released that morning.
Investors and the public can access the webcast through www.pfizer.com/investors. Participants can also join via phone by dialing 800-456-4352 (US/Canada) or 785-424-1086 (international) using passcode '67619'. The webcast replay and transcript will be available on Pfizer's investor website within 24 hours and remain accessible for 90 days.
Pfizer, with a 175-year legacy, continues its mission of developing innovative medicines and vaccines. The company emphasizes its commitment to quality healthcare, global wellness, and breakthrough therapies that address critical diseases.
Pfizer (NYSE: PFE) ha annunciato una conferenza telefonica con analisti finanziari programmata per il 29 aprile 2025 alle 10:00 EDT. La chiamata fornirà aggiornamenti sul Rapporto sulle Prestazioni del Primo Trimestre 2025, che sarà pubblicato quella mattina.
Gli investitori e il pubblico possono accedere al webcast tramite www.pfizer.com/investors. I partecipanti possono anche unirsi telefonicamente componendo il numero 800-456-4352 (USA/Canada) o 785-424-1086 (internazionale) utilizzando il codice di accesso '67619'. La registrazione e la trascrizione del webcast saranno disponibili sul sito web per gli investitori di Pfizer entro 24 ore e rimarranno accessibili per 90 giorni.
Pfizer, con una storia di 175 anni, continua la sua missione di sviluppare farmaci e vaccini innovativi. L'azienda sottolinea il suo impegno per la qualità della salute, il benessere globale e le terapie rivoluzionarie che affrontano malattie critiche.
Pfizer (NYSE: PFE) ha anunciado una conferencia telefónica con analistas de inversiones programada para el 29 de abril de 2025 a las 10:00 a.m. EDT. La llamada proporcionará actualizaciones sobre el Informe de Desempeño del Primer Trimestre de 2025, que se publicará esa mañana.
Los inversores y el público pueden acceder a la transmisión web a través de www.pfizer.com/investors. Los participantes también pueden unirse por teléfono marcando 800-456-4352 (EE.UU./Canadá) o 785-424-1086 (internacional) utilizando el código de acceso '67619'. La repetición de la transmisión web y la transcripción estarán disponibles en el sitio web para inversores de Pfizer dentro de 24 horas y permanecerán accesibles durante 90 días.
Pfizer, con una herencia de 175 años, continúa su misión de desarrollar medicamentos y vacunas innovadoras. La compañía enfatiza su compromiso con la atención médica de calidad, el bienestar global y las terapias innovadoras que abordan enfermedades críticas.
화이자 (NYSE: PFE)는 2025년 4월 29일 오전 10:00 EDT에 예정된 투자 분석가와의 컨퍼런스 콜을 발표했습니다. 이 통화에서는 그날 아침에 발표될 2025년 1분기 성과 보고서에 대한 업데이트가 제공될 것입니다.
투자자와 대중은 www.pfizer.com/investors를 통해 웹캐스트에 접속할 수 있습니다. 참가자는 전화로 800-456-4352 (미국/캐나다) 또는 785-424-1086 (국제)로 전화를 걸어 '67619' 비밀번호를 사용하여 참여할 수 있습니다. 웹캐스트 재생 및 기록은 24시간 이내에 화이자의 투자자 웹사이트에서 제공되며 90일 동안 접근 가능합니다.
175년의 유산을 지닌 화이자는 혁신적인 의약품과 백신을 개발하는 사명을 계속하고 있습니다. 이 회사는 양질의 의료, 글로벌 웰빙 및 중대한 질병을 해결하는 혁신적인 치료법에 대한 헌신을 강조합니다.
Pfizer (NYSE: PFE) a annoncé une conférence téléphonique avec des analystes financiers prévue pour le 29 avril 2025 à 10h00 EDT. L'appel fournira des mises à jour sur le Rapport de Performance du Premier Trimestre 2025, qui sera publié ce matin-là.
Les investisseurs et le public peuvent accéder au webcast via www.pfizer.com/investors. Les participants peuvent également se joindre par téléphone en composant le 800-456-4352 (États-Unis/Canada) ou le 785-424-1086 (international) en utilisant le code d'accès '67619'. La rediffusion du webcast et la transcription seront disponibles sur le site des investisseurs de Pfizer dans les 24 heures et resteront accessibles pendant 90 jours.
Pfizer, avec un héritage de 175 ans, continue sa mission de développement de médicaments et de vaccins innovants. L'entreprise souligne son engagement envers des soins de santé de qualité, le bien-être mondial et des thérapies révolutionnaires qui s'attaquent à des maladies critiques.
Pfizer (NYSE: PFE) hat eine Telefonkonferenz mit Investmentanalysten für den 29. April 2025 um 10:00 Uhr EDT angekündigt. Während des Anrufs werden Updates zum Leistungsbericht des ersten Quartals 2025 bereitgestellt, der an diesem Morgen veröffentlicht wird.
Investoren und die Öffentlichkeit können über www.pfizer.com/investors auf das Webcast zugreifen. Teilnehmer können auch telefonisch unter 800-456-4352 (USA/Kanada) oder 785-424-1086 (international) mit dem Zugangscode '67619' teilnehmen. Die Aufzeichnung und das Transkript des Webcasts werden innerhalb von 24 Stunden auf der Investorenseite von Pfizer verfügbar sein und für 90 Tage zugänglich bleiben.
Pfizer, mit einer 175-jährigen Geschichte, setzt seine Mission fort, innovative Medikamente und Impfstoffe zu entwickeln. Das Unternehmen betont sein Engagement für hochwertige Gesundheitsversorgung, globales Wohlbefinden und bahnbrechende Therapien zur Bekämpfung kritischer Krankheiten.
- None.
- None.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call.
You can also listen to the conference call by dialing either 800-456-4352 in
The transcript and webcast replay of the call will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live conference call and will be accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections, reorganizations, business plans, strategy, goals and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20250318748513/en/
Media:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
When is Pfizer's Q1 2025 earnings call and how can investors access it?
What information will be discussed in Pfizer's (PFE) upcoming earnings call?
How long will Pfizer's Q1 2025 earnings call webcast be available for replay?
What are the dial-in numbers for Pfizer's Q1 2025 earnings conference call?
